Scarica l'app Stockscreener
75.50
17.59%
-16.12
Dopo l'orario di chiusura:
77.01
1.51
+2.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific Corporation net sales up 15.9% to USD 5.286B in Q4 2025 - Medical Buyer
Boston Scientific’s Earnings Call Highlights Durable Growth - TipRanks
Stifel lowers Boston Scientific stock price target to $110 on EP results - Investing.com India
Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors - The Motley Fool
Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors - The Motley Fool
Boston Scientific (BSX) Exceeds Q4 2025 Financial Targets - GuruFocus
These stocks are today’s movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and more - MSN
Boston Scientific (BSX) stock dives on electrophysiology sales miss — what to watch after the bell - TechStock²
U.S. Markets Ended Wednesday Mixed As Super Micro Computer Led, Boston Scientific Lagged - Barron's
Boston Scientific stock price target lowered to $110 at BTIG on PFA concerns - Investing.com India
Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX - TechStock²
AMD, AbbVie, Boston Scientific, Eli Lilly, MP, Super Micro, Palantir, and More Movers - Barron's
Why Boston Scientific stock plummeted today - MSN
BTIG Cuts Boston Scientific Price Target to $110 From $132, Buy Rating Maintained - marketscreener.com
Boston Scientific Corp (BSX) Q4 2025 Earnings Call Highlights: Surpassing Financial Goals with Robust Growth - GuruFocus
Boston Scientific shares fall as key segment's performance spooks investors - marketscreener.com
Boston Scientific shares tumble on weak 2026 outlook - Investing.com
Boston Scientific slides after quarterly sales of key products disappoint - TradingView
Boston Scientific Still Has a Moat, but Slower PFA Growth Leads to Lower Fair Value Estimate - Morningstar
Why Boston Scientific Stock Plummeted Today - AOL.com
Boston Scientific continues to see electrophysiology success despite slowdown in growth - MedTech Dive
Why Boston Scientific (BSX) Shares Are Getting Obliterated Today - Yahoo Finance
BSX Stock Dips in Premarket Trading Despite Q4 Earnings, Revenue Beat - TradingView
Boston Scientific, AbbVie Beat Quarterly Views; Shares Slump Amid Weakness in Certain Segments - 富途牛牛
Piper Sandler Adjusts Price Target on Boston Scientific to $105 From $120, Maintains Overweight Rating - marketscreener.com
Boston Scientific posts Q4 beats as sales rise 16%, stock dips as EP sales come up short - MassDevice
Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat - marketscreener.com
What Spooked Investors In Boston Scientific’s 2026 Outlook? - Stocktwits
Boston Scientific Earnings Beat Estimates. It’s the Worst Stock in the S&P 500 Today. - Barron's
Boston Scientific shares slide on cautious 2026 revenue forecast - marketscreener.com
Boston Scientific sees Q1 adjusted EPS 78c-80c, consensus 80c - TipRanks
BSX Earnings: Boston Scientific Stock (BSX) Plunges 17% on Weak Guidance - TipRanks
Earnings call transcript: Boston Scientific beats Q4 2025 EPS, stock falls - Investing.com India
Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results - TipRanks
Boston Scientific stock hits 52-week low at 81.38 USD - Investing.com
Boston Scientific stock hits 52-week low at 81.38 USD By Investing.com - Investing.com Canada
Boston Scientific profit, sales rise but issues soft guidance - MSN
Boston Scientific (BSX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance Singapore
Boston Scientific Faces Market Turbulence Post Penumbra Acquisition Announcement - timothysykes.com
Boston Scientific (BSX) Shares Drop Following Q4 Results and FY2 - GuruFocus
Boston Scientific (BSX) Shares Drop Despite Beating Q4 2025 Esti - GuruFocus
Boston Scientific tops Q4 forecasts, shares slip modestly - MSN
Boston Scientific Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Boston Scientific reports Q4 adjusted EPS 80c, consensus 78c - TipRanks
Boston Scientific stock falls as electrophysiology division misses targets - Investing.com
Boston Scientific (NYSE:BSX) Reports Q4 CY2025 In Line With Expectations - Finviz
Boston Scientific Stock Slips On A Slower 2026 Outlook - Finimize
Boston Scientific to Acquire Valencia Technologies and Expand Bladder Care Portfolio - The Healthcare Technology Report.
Interested in our Q4 2025 earnings? - www.bostonscientific.com
Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
S&P 500 Futures Up in Premarket Trading; Mercury Systems, Boston Scientific Lag - Barron's
Boston Scientific Corp (NYSE:BSX) Stock Plummets 9% Despite Mixed Q4 2025 Earnings - Chartmill
Earnings Recap: Boston Scientific, CME, and Johnson Controls Deliver Quarterly Beats - Tokenist
Boston Scientific Corporation Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com
Boston Scientific Sees More Growth after Earnings, Sales Rise - marketscreener.com
Boston Scientific Q4 Adjusted Earnings, Revenue Rise; Q1, 2026 Adjusted EPS Outlooks Set - marketscreener.com
Boston Scientific (BSX) Exceeds Q4 Earnings and Revenue Expectat - GuruFocus
Boston Scientific (BSX) Exceeds Q4 Earnings and Revenue Estimates - GuruFocus
Boston Scientific (BSX) Surpasses Q4 Revenue Expectations - GuruFocus
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Boston Scientific Q4 earnings show revenue jumps 16% - grafa.com
Boston Scientific beats Q4 estimates, shares dip slightly By Investing.com - Investing.com Nigeria
Boston Scientific Q4 and Full Year 2025 Financial Results - TradingView
Boston Scientific: Q4 Earnings Snapshot - marketscreener.com
Boston Scientific beats Q4 estimates, shares dip slightly - Investing.com
Boston Scientific Corp Profit Climbs In Q4 - Nasdaq
Earnings Flash (BSX) Boston Scientific Corporation Reports Q4 Revenue $5.29B, vs. FactSet Est of $5.28B - marketscreener.com
1.30%
4.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):